BALVERSA vs IMFINZI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. BALVERSA and IMFINZI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BALVERSA	IMFINZI
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ERDAFITINIB	DURVALUMAB
Manufacturer	Janssen Biotech	Astrazeneca UK Ltd
Dosage forms	Tablet	Injectable
Drug class	—	Programmed Death Ligand-1 Blocker
Boxed warning	None	None
Treats	Transitional Cell Carcinoma	Transitional Cell Carcinoma

balversa imfinzi

Rating

New

Pharmacy pays

—

Type

Active ingredient

ERDAFITINIB

DURVALUMAB

Manufacturer

Janssen Biotech

Astrazeneca UK Ltd

Dosage forms

Tablet

Injectable

Drug class

—

Programmed Death Ligand-1 Blocker

Boxed warning

None

Treats

Transitional Cell Carcinoma

Frequently asked questions

What is the difference between Balversa and Imfinzi?

Balversa contains Erdafitinib, while Imfinzi contains Durvalumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.